EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis

Fang Li, Fang-Jian Zhou, Tong-Wei Zhu, Hua-Li Qiu, Xiao-Ting Zhang, Bo-Wen Ruan, De-Yi Huang

Advances in Clinical and Experimental Medicine · 2023

DOI: 10.17219/acem/157240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Fang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The People's Hospital of Yuhuan, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Skip lymph node metastasis (SLNM) refers to lateral lymph node metastasis (LLNM) without involving central lymph node (CLN). Some microscopic nodal positivity may be difficult to detect before surgery due to atypical imaging characteristics. These patients are misdiagnosed as having clinically node-negative (cN0) papillary thyroid cancer (PTC) even after central lymph node dissection, leading to a high risk of developing LNM after surgery. Current prediction models have limited clinical utility, as they are only applicable to predict SLNM from clinically node-positive (cN+) PTC, not cN0 PTC, and this has little impact on treatment strategies. OBJECTIVES: This study aimed to establish a nomogram for preoperatively assessing the likelihood of SLNM in cN0 PTC patients with increased risk of LNM, thus optimizing their therapeutic options. MATERIAL AND METHODS: The records of 780 PTC patients undergoing thyroidectomy along with bilateral central lymph node dissection were retrospectively reviewed. The cN0 patients with postoperative LLNM (occult SLNM) and cN+ patients without central lymph node metastasis (CLNM) (typical SLNM) were included in the SLNM group (n = 82). The CLNM-negative cN0 patients without postoperative LLNM were assigned to the non-SLNM group (n = 698). The independent correlates of SLNM constituted the nomogram for determining the likelihood of SLNM in high-risk cN0 PTC patients. RESULTS: The independent correlates of SLNM were age (hazard ratio (HR) = 1.016), tumor location (HR = 1.801), tumor size (HR = 1.528), and capsular invasion (HR = 2.941). They served as components in the development of the nomogram. This model was verified to present acceptable discrimination. It showed good calibration and a decent net benefit when the predicted probability was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryHumansThyroid Cancer, PapillaryLymphatic MetastasisNomogramsRetrospective StudiesLymph NodesRisk Factors

Stichwörter der Autor:innen

central lymph node metastasisclinically node-negative (cN0)nomogrampapillary thyroid cancerskip lymph node metastasis

Autor:innen und Institutionen

  • Department of Ultrasound, The People's Hospital of Yuhuan, China.
  • The Second Department of General Surgery, The People's Hospital of Yuhuan, China.
  • Department of Ultrasound, Taizhou Hospital of Zhejiang Province, China.

Zitieren

APA

Li, F., Zhou, F. J., Zhu, T. W., Qiu, H. L., Zhang, X. T., Ruan, B. W., & Huang, D. Y. (2023). Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/157240

Vancouver

Li F, Zhou FJ, Zhu TW, Qiu HL, Zhang XT, Ruan BW, et al. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/157240

BibTeX
@article{Li2023,
  author = {Li, Fang and Zhou, Fang-Jian and Zhu, Tong-Wei and Qiu, Hua-Li and Zhang, Xiao-Ting and Ruan, Bo-Wen and Huang, De-Yi},
  title = {Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2023},
  doi = {10.17219/acem/157240}
}
Kostenlos starten →